Emixustat

DRUG2 trials

Sponsors

Kubota Vision Inc.

Conditions

Macular AtrophyStargardt Disease

Phase 2

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

CompletedNCT03033108

Kubota Vision Inc.Macular Atrophy, Stargardt Disease

Start: 2017-01-31End: 2017-12-31Updated: 2021-05-19

Phase 3

Safety and Efficacy of Emixustat in Stargardt Disease

CompletedNCT03772665

Kubota Vision Inc.Stargardt Disease

Start: 2019-01-07End: 2022-06-23Updated: 2024-05-30

Related Papers

Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates

JCI Insight2022-01-2424 citations